SANTA CLARA, Calif.--(BUSINESS WIRE)--Iris BioTechnologies (OTCBB:IRSB) (http://www.irisbiotech.com), a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, has launched its proprietary BioWindows™ 2.0 to further the progress of personalized and targeted medicine.
